Sanofi (SNYNF) Share-based Compensation (2013 - 2021)

Sanofi has disclosed Share-based Compensation across 4 years of filings, most recently posting $2.1 million for Q4 2021.

• Share-based Compensation for Q4 2021 came in at $2.1 million, up 7.94% year-over-year; the trailing twelve-month figure through Dec 2021 was $116.5 million (up 1.8% YoY), and the FY2025 annual result was $364.3 million, up 22.65% from the prior year.
• Share-based Compensation came in at $2.1 million for Q4 2021 at Sanofi, up from $1.9 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $2.1 million in Q4 2021 to a low of $1.5 million in Q4 2019.
• The 3-year median for Share-based Compensation is $1.9 million (2020), against an average of $1.8 million.
• Across the five-year window, Share-based Compensation advanced 23.1% in 2020 and grew 7.94% in 2021, its largest moves.
• Sanofi's Share-based Compensation stood at $1.5 million in 2019, then advanced by 23.1% to $1.9 million in 2020, then rose by 7.94% to $2.1 million in 2021.
• The last three Share-based Compensation figures came in at $2.1 million (Q4 2021), $1.9 million (Q4 2020), and $1.5 million (Q4 2019), per Business Quant data.